Healthcare


 Imugene Presents New HER-Vaxx Data At ESMO World Congress On Gastrointestinal Cancer

Imugene Presents New HER-Vaxx Data At ESMO World Congress On Gastrointestinal Cancer

July 08, 2019 08:37 PM AEST| By Team Kalkine Media

A biotechnology company listed on the Australian Stock Exchange (ASX), Imugene Limited (ASX: IMU) develops cancer immunotherapies targeting B-cell peptide vaccines. The immunotherapies developed by the company seek to activate the cancer patients? im...

 Latest Updates on Four Healthcare Stocks - SOM, ADO, VHT, IMU

Latest Updates on Four Healthcare Stocks - SOM, ADO, VHT, IMU

July 08, 2019 06:28 PM AEST| By Team Kalkine Media

Health and medical industry of Australia focuses on the world?s leading technology, advanced research, development and innovation. Over the years, the industry has registered strong growth in terms of both size and reputation. Let us discuss four co...

 A Glance At Medical Device Company, Osprey Medical, Inc.

A Glance At Medical Device Company, Osprey Medical, Inc.

July 05, 2019 06:09 PM AEST| By Team Kalkine Media

Headquartered in the United States, Osprey Medical, Inc. (ASX: OSP) is engaged in protecting patients from the adverse effects of X-ray dye used commonly while performing the angiographic imaging procedures. Osprey aims to make heart imaging procedur...

 Potential ground-breaking outcomes for Veyonda<sup>®</sup> at SNMMI 2019 Conference

Potential ground-breaking outcomes for Veyonda® at SNMMI 2019 Conference

July 05, 2019 12:46 PM AEST| By Team Kalkine Media

In the world of cancer, one?billion-dollar molecule that has been making?a?big noise for its potential to extend life in men with the late-stage prostate cancer,?concerns an experimental radioactive drug called Lutetium-177 (177Lu) labelled PSMA-617...

 Prescient Therapeutics’ drug candidates addressing the mutations causing cancer

Prescient Therapeutics’ drug candidates addressing the mutations causing cancer

July 02, 2019 02:54 PM AEST| By Team Kalkine Media

Clinical-Stage oncology company, Prescient Therapeutics Limited (ASX: PTX) bases the foundation of its business model on the ground-breaking technology that addresses the mutations causing cancer. The company?s mainstream operations are focused on th...

 A look at Manufacturing, Healthcare and Marketing stocks- TTT, BDA, PPL

A look at Manufacturing, Healthcare and Marketing stocks- TTT, BDA, PPL

July 01, 2019 02:32 PM AEST| By Team Kalkine Media

Titomic Limited The digital manufacturing solutions company, Titomic (ASX: TTT) is headquartered in Melbourne, Australia, and engaged in the additive manufacturing sector. Its proprietary Titomic Kinetic Fusion? (TKF) technology is designed to perfo...

 Another tick for Noxopharm’s Veyonda<sup>®</sup> at SNMMI 2019 Annual Meeting

Another tick for Noxopharm’s Veyonda® at SNMMI 2019 Annual Meeting

July 01, 2019 12:34 PM AEST| By Team Kalkine Media

The big noise internationally in the treatment of prostate cancer is an experimental drug called 177Lu-PSMA-617. It is what is called a radiopharmaceutical, meaning that it is a radioactive drug that is injected intravenously. It is a way of getting...

 Healthcare Players On An Uptrend This Year- OCC, PAR And SHL

Healthcare Players On An Uptrend This Year- OCC, PAR And SHL

June 30, 2019 09:00 AM AEST| By Team Kalkine Media

The Australian economy, like many countries, is facing challenges in terms of an ageing population, rising chronic diseases, rising demand for new treatments and more hospital beds. S&P/ASX 200 Health Care Index generated an annual return of 9.92...

 Three Healthcare Stocks In Focus - CSL, COH, RHC

Three Healthcare Stocks In Focus - CSL, COH, RHC

June 29, 2019 09:15 AM AEST| By Team Kalkine Media

The Australian healthcare sector has been witnessing rapid advancements and innovations. Besides, healthcare is performing well in multiple State Budgets as well as the Federal Budget as announced earlier in 2018. Thus, the healthcare industry can ex...

 A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy

June 28, 2019 04:36 PM AEST| By Team Kalkine Media

An Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treating a variety of cancers. The company?s pipeline includes multiple product candidates that are used...

 A Glance at Australia’s Healthcare System; Two Health Stocks in Discussion –SHL, CSL

A Glance at Australia’s Healthcare System; Two Health Stocks in Discussion –SHL, CSL

June 27, 2019 04:32 PM AEST| By Team Kalkine Media

As defined by the World Health Organization, the health system constitutes all those activities that are aimed at promoting, restoring and maintaining health. A health care system provides services that contribute towards the health of the individual...

 3 Penny Stocks In The Healthcare Domain - DXB, RHY, BNO

3 Penny Stocks In The Healthcare Domain - DXB, RHY, BNO

June 26, 2019 08:24 PM AEST| By Team Kalkine Media

Dimerix Limited (ASX: DXB) Clinical-stage biopharmaceutical company, Dimerix Limited (ASX: DXB) is engaged in developing new therapies for the unmet requirements of the medicine market all over the world. On 26 June 2019, Dimerix announced an update...

 2 Healthcare Stars Under Spotlight - MSB And KZA

2 Healthcare Stars Under Spotlight - MSB And KZA

June 25, 2019 05:00 PM AEST| By Team Kalkine Media

The healthcare industry of Australia plays a major role in developing the country?s economy. The healthcare sector witnessed an increase in the demand for health services by Australia's growing and ageing population. The growth in the industry has be...

 Here’s Why Althea Group Is Up By 7% Today?

Here’s Why Althea Group Is Up By 7% Today?

June 25, 2019 03:55 PM AEST| By Team Kalkine Media

Melbourne-based Althea Group Holdings Limited (ASX: AGH) is engaged in the cultivation and supply of pharmaceutical grade medicinal cannabis domestically and internationally. Althea is one of the few companies that has been granted the full suite of...

 An Insight into Imugene’s Unique Platform Technology

An Insight into Imugene’s Unique Platform Technology

June 24, 2019 01:02 PM AEST| By Team Kalkine Media

Imugene Limited (ASX: IMU) is a clinical-stage immuno-oncology company headquartered in Australia that is engaged in developing a range of immunotherapies used to treat and eradicate tumors. The company’s operations are spread across America an...

 A Sneak-Peak Into 3 Large Cap Healthcare Players – RMD, COH, SHL

A Sneak-Peak Into 3 Large Cap Healthcare Players – RMD, COH, SHL

June 23, 2019 08:00 AM AEST| By Team Kalkine Media

Large Cap Stocks: Large cap stocks are those stocks which have a market capitalization of $10 billion or above. Investors prefer to invest in large cap stocks, as these are the stocks of big companies and are stable in nature. It is less likely that...

 3 Healthcare Stocks - MXC, IMM, AGH

3 Healthcare Stocks - MXC, IMM, AGH

June 21, 2019 11:54 PM AEST| By Team Kalkine Media

The below-mentioned health care stocks have come up with significant updates today. Let’s take a quick look at these stocks. MGC Pharmaceuticals Ltd (ASX: MXC) The European based biopharma company, MGC Pharmaceuticals Ltd (ASX: MXC) has sign...

 Three Healthcare stocks – COH, CSL, RMD

Three Healthcare stocks – COH, CSL, RMD

June 18, 2019 04:29 PM AEST| By Team Kalkine Media

Australia has one of the best healthcare systems in the world in terms of cost, access, and quality of services and products offered. Globally, health is challenged by demographic and economic changes, threatening a country?s ability to deliver the l...

 Noxopharm: Developing Veyonda® As A Universal Treatment Of Metastatic Cancer Disease

Noxopharm: Developing Veyonda® As A Universal Treatment Of Metastatic Cancer Disease

June 18, 2019 01:38 PM AEST| By Team Kalkine Media

Clinical-stage drug development company, Noxopharm Limited (ASX: NOX) has released its updated corporate presentation for June 2019. The company, with offices in Sydney, New York and Hong Kong, is developing its leading drug candidate, Veyonda? as a...

 Two Cannabis Stocks - THC and MXC - Spike On Recent Updates

Two Cannabis Stocks - THC and MXC - Spike On Recent Updates

June 13, 2019 11:50 PM AEST| By Team Kalkine Media

Medical cannabis is becoming popular in the pharmaceutical industry, with more and more countries legalising cannabis for its use as a medicinal product. Growing number of research bodies are supporting the use of cannabis and cannabis-based products...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.